Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study

Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study

Abstract Background Although hydroxychloroquine (HCQ) is a mainstay of treatment for patients with systemic lupus erythematosus (SLE), ocular toxicity can result from accumulated exposure. As the longevity of patients with SLE improves, data are needed to balance the risk of ocular toxicity and the...

Full description

Bibliographic Details
Main Authors: Ruth Fernandez-Ruiz, Nicole Bornkamp, Mimi Y. Kim, Anca Askanase, Anna Zezon, Chung-E Tseng, H. Michael Belmont, Amit Saxena, Jane E. Salmon, Michael Lockshin, Jill P. Buyon, Peter M. Izmirly
Format: Article
Language:English
Published: BMC 2020-08-01
Series:Arthritis Research & Therapy
Subjects:
Lupus
Hydroxychloroquine
Maculopathy
Online Access:http://link.springer.com/article/10.1186/s13075-020-02282-0

Internet

http://link.springer.com/article/10.1186/s13075-020-02282-0

Similar Items